title: [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
authors: Neurologiska kliniken, Universitetssjukhuset, Linköping.
authors: J E
authors: JE
authors: Olsson
authors: M
authors: M
authors: Duchek
authors: R
authors: R
authors: Ekberg
authors: C
authors: C
authors: Fehling
authors: F
authors: F
authors: Johansson
authors: B
authors: B
authors: Johnels
authors: B
authors: B
authors: Lindvall
authors: G
authors: G
authors: Nordin
authors: A
authors: A
authors: Sidén
authors: G
authors: G
authors: Steg
mesh_terms: D001971:Bromocriptine / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000139:chemically induced; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D013997:Time Factors
chemical_list: D001971:Bromocriptine; D007980:Levodopa
vernacular_title: L-dopa och bromokriptin vid Parkinsons sjukdom. Tidig kombination ger b attre effekt.